English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau δK280

MPS-Authors
/persons/resource/persons147310

Sydow,  Astrid
Eckhard Mandelkow, Emeriti, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons94203

Mandelkow,  Eckhard
Eckhard Mandelkow, Emeriti, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons128150

Mandelkow,  Eva-Maria
Eckhard Mandelkow, Emeriti, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

External Ressource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Dennissen, F. J. A., Anglada-Huguet, M., Sydow, A., Mandelkow, E., & Mandelkow, E.-M. (2016). Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau δK280. Proceedings of the National Academy of Sciences of the United States of America, 113(41), 11597-11602. doi:10.1073/pnas.1603119113.


Cite as: http://hdl.handle.net/11858/00-001M-0000-002B-A8F3-2
Abstract
There is no abstract available